Victor Sarantschin

Victor Sarantschin is an experienced professional in business development and account management within the biopharmaceutical sector. Currently serving as the Sr. Account Manager and Global Licensing Lead at Advancion Corporation since April 2023, Victor is responsible for business development of ANGUS' Buffer and Biochemicals for pharma and biotech applications and leads global licensing for Expression Systems. Previously, Victor held positions including Director of Business Development at Curia, focusing on large molecules and mRNA in the Western US, and Business Development and Licensing Specialist at Lonza, where responsibilities included the licensing of gene expression technologies. Victor's extensive experience also includes senior roles at ANGUS/Dow Chemical Company, Dow, Neose Technologies, and Tosoh Bioscience, contributing to a strong background in the commercialization and technical marketing of bioprocessing technologies.